EPIRUS Biopharmaceuticals
Latest round
- Series B
Last raised
- Apr 2014
Total raised
- $36M
Investors
- 9
About EPIRUS Biopharmaceuticals
Epirus is a US-based company that focuses on the development of biosimilar products.
Who invested in EPIRUS Biopharmaceuticals
9 investors across 1 round
See all investors in EPIRUS Biopharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Apr 16, 2014
Amount
$36M
Investors
Questions about EPIRUS Biopharmaceuticals
Who invested in EPIRUS Biopharmaceuticals?
EPIRUS Biopharmaceuticals has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EPIRUS Biopharmaceuticals raised?
EPIRUS Biopharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did EPIRUS Biopharmaceuticals last raise money?
EPIRUS Biopharmaceuticals's most recent round on record is a Series B, in Apr 2014.
What does EPIRUS Biopharmaceuticals do?
Epirus is a US-based company that focuses on the development of biosimilar products.
Where is EPIRUS Biopharmaceuticals headquartered?
EPIRUS Biopharmaceuticals is headquartered in Boston, US.
Which VCs invest in companies like EPIRUS Biopharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at EPIRUS Biopharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like EPIRUS Biopharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.